Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 187

1.

Risk, Risk Factors, and Surveillance of Subsequent Malignant Neoplasms in Survivors of Childhood Cancer: A Review.

Turcotte LM, Neglia JP, Reulen RC, Ronckers CM, van Leeuwen FE, Morton LM, Hodgson DC, Yasui Y, Oeffinger KC, Henderson TO.

J Clin Oncol. 2018 Jul 20;36(21):2145-2152. doi: 10.1200/JCO.2017.76.7764. Epub 2018 Jun 6.

PMID:
29874133
2.

Late Infection-Related Mortality in Asplenic Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study.

Weil BR, Madenci AL, Liu Q, Howell RM, Gibson TM, Yasui Y, Neglia JP, Leisenring WM, Smith SA, Tonorezos ES, Friedman DN, Constine LS, Tinkle CL, Diller LR, Armstrong GT, Oeffinger KC, Weldon CB.

J Clin Oncol. 2018 Jun 1;36(16):1571-1578. doi: 10.1200/JCO.2017.76.1643. Epub 2018 Apr 17.

PMID:
29664715
3.

Consequences of cure: subsequent therapy-related cancers.

Turcotte LM, Neglia JP.

Oncotarget. 2017 Dec 6;8(70):114424-114425. doi: 10.18632/oncotarget.23003. eCollection 2017 Dec 29. No abstract available.

4.

Genome-Wide Association Study to Identify Susceptibility Loci That Modify Radiation-Related Risk for Breast Cancer After Childhood Cancer.

Morton LM, Sampson JN, Armstrong GT, Chen TH, Hudson MM, Karlins E, Dagnall CL, Li SA, Wilson CL, Srivastava DK, Liu W, Kang G, Oeffinger KC, Henderson TO, Moskowitz CS, Gibson TM, Merino DM, Wong JR, Hammond S, Neglia JP, Turcotte LM, Miller J, Bowen L, Wheeler WA, Leisenring WM, Whitton JA, Burdette L, Chung C, Hicks BD, Jones K, Machiela MJ, Vogt A, Wang Z, Yeager M, Neale G, Lear M, Strong LC, Yasui Y, Stovall M, Weathers RE, Smith SA, Howell R, Davies SM, Radloff GA, Onel K, Berrington de González A, Inskip PD, Rajaraman P, Fraumeni JF Jr, Bhatia S, Chanock SJ, Tucker MA, Robison LL.

J Natl Cancer Inst. 2017 Nov 1;109(11). doi: 10.1093/jnci/djx058.

PMID:
29059430
5.

Longitudinal assessment of late-onset neurologic conditions in survivors of childhood central nervous system tumors: a Childhood Cancer Survivor Study report.

Wells EM, Ullrich NJ, Seidel K, Leisenring W, Sklar CA, Armstrong GT, Diller L, King A, Krull KR, Neglia JP, Stovall M, Whelan K, Oeffinger KC, Robison LL, Packer RJ.

Neuro Oncol. 2018 Jan 10;20(1):132-142. doi: 10.1093/neuonc/nox148.

PMID:
29016809
6.

Subsequent malignant neoplasms in the survivor of childhood cancer: where we have been and where we are going?

Turcotte LM, Neglia JP.

Future Oncol. 2017 Oct;13(23):2013-2016. doi: 10.2217/fon-2017-0331. Epub 2017 Oct 6. No abstract available.

PMID:
28984464
7.

Clinical and Genetic Risk Prediction of Subsequent CNS Tumors in Survivors of Childhood Cancer: A Report From the COG ALTE03N1 Study.

Wang X, Sun CL, Hageman L, Smith K, Singh P, Desai S, Hawkins DS, Hudson MM, Mascarenhas L, Neglia JP, Oeffinger KC, Ritchey AK, Robison LL, Villaluna D, Landier W, Bhatia S.

J Clin Oncol. 2017 Nov 10;35(32):3688-3696. doi: 10.1200/JCO.2017.74.7444. Epub 2017 Oct 4.

PMID:
28976792
8.

Reply to Second malignancies in Ewing sarcoma survivors.

Marina NM, Liu Q, Donaldson SS, Sklar CA, Armstrong GT, Oeffinger KC, Leisenring WM, Ginsberg JP, Henderson TO, Neglia JP, Stovall MA, Yasui Y, Randall RL, Geller DS, Robison LL, Ness KK.

Cancer. 2017 Oct 15;123(20):4075-4076. doi: 10.1002/cncr.30921. Epub 2017 Aug 24. No abstract available.

PMID:
28837220
9.

Temporal Changes in Subsequent Malignancies Among Childhood Cancer Survivors-Reply.

Turcotte LM, Yasui Y, Neglia JP.

JAMA. 2017 Jun 20;317(23):2451-2452. doi: 10.1001/jama.2017.6028. No abstract available.

PMID:
28632863
10.

Radiation-associated breast cancer and gonadal hormone exposure: a report from the Childhood Cancer Survivor Study.

Moskowitz CS, Chou JF, Sklar CA, Barnea D, Ronckers CM, Friedman DN, Neglia JP, Turcotte L, Howell RM, Henderson TO, Armstrong GT, Leisenring WM, Robison LL, van Leeuwen FE, Pike MC, Oeffinger KC.

Br J Cancer. 2017 Jul 11;117(2):290-299. doi: 10.1038/bjc.2017.169. Epub 2017 Jun 20.

11.

Identifying metrics of success for transitional care practices in childhood cancer survivorship: A qualitative study of survivorship providers.

Sadak KT, Neglia JP, Freyer DR, Harwood E.

Pediatr Blood Cancer. 2017 Nov;64(11). doi: 10.1002/pbc.26587. Epub 2017 May 30.

PMID:
28557375
12.

Morbidity and Mortality Associated With Meningioma After Cranial Radiotherapy: A Report From the Childhood Cancer Survivor Study.

Bowers DC, Moskowitz CS, Chou JF, Mazewski CM, Neglia JP, Armstrong GT, Leisenring WM, Robison LL, Oeffinger KC.

J Clin Oncol. 2017 May 10;35(14):1570-1576. doi: 10.1200/JCO.2016.70.1896. Epub 2017 Mar 24.

13.

Temporal Trends in Treatment and Subsequent Neoplasm Risk Among 5-Year Survivors of Childhood Cancer, 1970-2015.

Turcotte LM, Liu Q, Yasui Y, Arnold MA, Hammond S, Howell RM, Smith SA, Weathers RE, Henderson TO, Gibson TM, Leisenring W, Armstrong GT, Robison LL, Neglia JP.

JAMA. 2017 Feb 28;317(8):814-824. doi: 10.1001/jama.2017.0693.

14.

Longitudinal follow-up of adult survivors of Ewing sarcoma: A report from the Childhood Cancer Survivor Study.

Marina NM, Liu Q, Donaldson SS, Sklar CA, Armstrong GT, Oeffinger KC, Leisenring WM, Ginsberg JP, Henderson TO, Neglia JP, Stovall MA, Yasui Y, Randall RL, Geller DS, Robison LL, Ness KK.

Cancer. 2017 Jul 1;123(13):2551-2560. doi: 10.1002/cncr.30627. Epub 2017 Feb 21.

15.

The Behavior Rating Inventory of Executive Function (BRIEF) to Identify Pediatric Acute Lymphoblastic Leukemia (ALL) Survivors At Risk for Neurocognitive Impairment.

Viola A, Balsamo L, Neglia JP, Brouwers P, Ma X, Kadan-Lottick NS.

J Pediatr Hematol Oncol. 2017 Apr;39(3):174-178. doi: 10.1097/MPH.0000000000000761.

16.

Health-related Quality of Life (HR-QOL) and Chronic Health Conditions in Survivors of Childhood Acute Myeloid Leukemia (AML) with Down Syndrome (DS): A Report From the Children's Oncology Group.

Schultz KA, Chen L, Kunin-Batson A, Chen Z, Woods WG, Gamis A, Kawashima T, Oeffinger KC, Nicholson HS, Neglia JP.

J Pediatr Hematol Oncol. 2017 Jan;39(1):20-25.

17.

Effect of Temporal Changes in Therapeutic Exposure on Self-reported Health Status in Childhood Cancer Survivors.

Ness KK, Hudson MM, Jones KE, Leisenring W, Yasui Y, Chen Y, Stovall M, Gibson TM, Green DM, Neglia JP, Henderson TO, Casillas J, Ford JS, Effinger KE, Krull KR, Armstrong GT, Robison LL, Oeffinger KC, Nathan PC.

Ann Intern Med. 2017 Jan 17;166(2):89-98. doi: 10.7326/M16-0742. Epub 2016 Nov 8.

18.

A randomized controlled pilot trial of a Web-based resource to improve cancer knowledge in adolescent and young adult survivors of childhood cancer.

Kunin-Batson A, Steele J, Mertens A, Neglia JP.

Psychooncology. 2016 Nov;25(11):1308-1316. doi: 10.1002/pon.3956. Epub 2015 Sep 25.

19.

Somatic and Germline TP53 Alterations in Second Malignant Neoplasms from Pediatric Cancer Survivors.

Sherborne AL, Lavergne V, Yu K, Lee L, Davidson PR, Mazor T, Smirnoff IV, Horvai AE, Loh M, DuBois SG, Goldsby RE, Neglia JP, Hammond S, Robison LL, Wustrack R, Costello JF, Nakamura AO, Shannon KM, Bhatia S, Nakamura JL.

Clin Cancer Res. 2017 Apr 1;23(7):1852-1861. doi: 10.1158/1078-0432.CCR-16-0610. Epub 2016 Sep 28.

20.

Risk and impact of pulmonary complications in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study.

Dietz AC, Chen Y, Yasui Y, Ness KK, Hagood JS, Chow EJ, Stovall M, Neglia JP, Oeffinger KC, Mertens AC, Robison LL, Armstrong GT, Mulrooney DA.

Cancer. 2016 Dec 1;122(23):3687-3696. doi: 10.1002/cncr.30200. Epub 2016 Aug 9.

21.

Childhood cancer survivorship research in minority populations: A position paper from the Childhood Cancer Survivor Study.

Bhatia S, Gibson TM, Ness KK, Liu Q, Oeffinger KC, Krull KR, Nathan PC, Neglia JP, Leisenring W, Yasui Y, Robison LL, Armstrong GT.

Cancer. 2016 Aug 1;122(15):2426-39. doi: 10.1002/cncr.30072. Epub 2016 Jun 2.

22.

A Comparative Evaluation of Normal Tissue Doses for Patients Receiving Radiation Therapy for Hodgkin Lymphoma on the Childhood Cancer Survivor Study and Recent Children's Oncology Group Trials.

Zhou R, Ng A, Constine LS, Stovall M, Armstrong GT, Neglia JP, Friedman DL, Kelly K, FitzGerald TJ, Hodgson DC.

Int J Radiat Oncol Biol Phys. 2016 Jun 1;95(2):707-11. doi: 10.1016/j.ijrobp.2016.01.053. Epub 2016 Feb 4.

23.

Radiation-Related New Primary Solid Cancers in the Childhood Cancer Survivor Study: Comparative Radiation Dose Response and Modification of Treatment Effects.

Inskip PD, Sigurdson AJ, Veiga L, Bhatti P, Ronckers C, Rajaraman P, Boukheris H, Stovall M, Smith S, Hammond S, Henderson TO, Watt TC, Mertens AC, Leisenring W, Stratton K, Whitton J, Donaldson SS, Armstrong GT, Robison LL, Neglia JP.

Int J Radiat Oncol Biol Phys. 2016 Mar 15;94(4):800-7. doi: 10.1016/j.ijrobp.2015.11.046. Epub 2015 Dec 15.

24.

CELF4 Variant and Anthracycline-Related Cardiomyopathy: A Children's Oncology Group Genome-Wide Association Study.

Wang X, Sun CL, Quiñones-Lombraña A, Singh P, Landier W, Hageman L, Mather M, Rotter JI, Taylor KD, Chen YD, Armenian SH, Winick N, Ginsberg JP, Neglia JP, Oeffinger KC, Castellino SM, Dreyer ZE, Hudson MM, Robison LL, Blanco JG, Bhatia S.

J Clin Oncol. 2016 Mar 10;34(8):863-70. doi: 10.1200/JCO.2015.63.4550. Epub 2016 Jan 25.

25.

Reduction in Late Mortality among 5-Year Survivors of Childhood Cancer.

Armstrong GT, Chen Y, Yasui Y, Leisenring W, Gibson TM, Mertens AC, Stovall M, Oeffinger KC, Bhatia S, Krull KR, Nathan PC, Neglia JP, Green DM, Hudson MM, Robison LL.

N Engl J Med. 2016 Mar 3;374(9):833-42. doi: 10.1056/NEJMoa1510795. Epub 2016 Jan 13.

26.

Breast Cancer Risk in Childhood Cancer Survivors Without a History of Chest Radiotherapy: A Report From the Childhood Cancer Survivor Study.

Henderson TO, Moskowitz CS, Chou JF, Bradbury AR, Neglia JP, Dang CT, Onel K, Novetsky Friedman D, Bhatia S, Strong LC, Stovall M, Kenney LB, Barnea D, Lorenzi E, Hammond S, Leisenring WM, Robison LL, Armstrong GT, Diller LR, Oeffinger KC.

J Clin Oncol. 2016 Mar 20;34(9):910-8. doi: 10.1200/JCO.2015.62.3314. Epub 2015 Dec 23.

27.

The Association Between Motor Skills and Academic Achievement Among Pediatric Survivors of Acute Lymphoblastic Leukemia.

Balsamo LM, Sint KJ, Neglia JP, Brouwers P, Kadan-Lottick NS.

J Pediatr Psychol. 2016 Apr;41(3):319-28. doi: 10.1093/jpepsy/jsv103. Epub 2015 Oct 29.

28.

Breast cancer following spinal irradiation for a childhood cancer: A report from the Childhood Cancer Survivor Study.

Moskowitz CS, Malhotra J, Chou JF, Wolden SL, Weathers RE, Stovall M, Armstrong GT, Leisenring WM, Neglia JP, Robison LL, Oeffinger KC.

Radiother Oncol. 2015 Nov;117(2):213-6. doi: 10.1016/j.radonc.2015.09.016. Epub 2015 Sep 18.

29.

Feasibility Study of a Novel Experimental Induction Protocol Combining B43-PAP (Anti-CD19) Immunotoxin With Standard Induction Chemotherapy in Children and Adolescents With Relapsed B-Lineage ALL: A Report From the Children's Oncology Group.

Meany HJ, Seibel NL, Krailo M, Villaluna D, Chen Z, Gaynon P, Neglia JP, Park JR, Hutchinson R, Sato JK, Wells RJ, Woods WG, Reaman G.

J Immunother. 2015 Sep;38(7):299-305. doi: 10.1097/CJI.0000000000000088.

30.

Risk of Subsequent Neoplasms During the Fifth and Sixth Decades of Life in the Childhood Cancer Survivor Study Cohort.

Turcotte LM, Whitton JA, Friedman DL, Hammond S, Armstrong GT, Leisenring W, Robison LL, Neglia JP.

J Clin Oncol. 2015 Nov 1;33(31):3568-75. doi: 10.1200/JCO.2015.60.9487. Epub 2015 Aug 10.

31.

Pilot study of intravenous melphalan combined with continuous infusion L-S,R-buthionine sulfoximine for children with recurrent neuroblastoma.

Anderson CP, Matthay KK, Perentesis JP, Neglia JP, Bailey HH, Villablanca JG, Groshen S, Hasenauer B, Maris JM, Seeger RC, Reynolds CP.

Pediatr Blood Cancer. 2015 Oct;62(10):1739-46. doi: 10.1002/pbc.25594. Epub 2015 Jul 7.

PMID:
26153194
32.

Reply to: Obesity is an important health problem in survivors of pediatric acute lymphoblastic leukemia.

Lindemulder SJ, Stork LC, Lu X, Hunger S, Neglia JP, Kadan-Lottick NS.

Pediatr Blood Cancer. 2015 Nov;62(11):2057. doi: 10.1002/pbc.25615. Epub 2015 Jul 1. No abstract available.

PMID:
26138788
33.

Survivors of standard risk acute lymphoblastic leukemia do not have increased risk for overweight and obesity compared to non-cancer peers: a report from the Children's Oncology Group.

Lindemulder SJ, Stork LC, Bostrom B, Lu X, Devidas M, Hunger S, Neglia JP, Kadan-Lottick NS.

Pediatr Blood Cancer. 2015 Jun;62(6):1035-41. doi: 10.1002/pbc.25411. Epub 2015 Feb 7.

34.

A systematic review of selected musculoskeletal late effects in survivors of childhood cancer.

Gawade PL, Hudson MM, Kaste SC, Neglia JP, Wasilewski-Masker K, Constine LS, Robison LL, Ness KK.

Curr Pediatr Rev. 2014;10(4):249-62. Review.

35.

Successful Spinal Fixation Surgery Following Teriparatide Treatment in an Adolescent Boy with Severe Osteoporosis and Progressive Kyphoscoliosis: A Case Report.

Oberdorfer E, Polly D, Larson-Ode K, Smith-Wright D, Guidera K, Neglia JP, Polgreen LE.

JBJS Case Connect. 2014 Oct/Dec/Nov;4(4):e89. doi: 10.2106/JBJS.CC.M.00296. No abstract available.

PMID:
29252757
36.

Feasibility and preliminary efficacy of the effects of flavanoid-rich purple grape juice on the vascular health of childhood cancer survivors: a randomized, controlled crossover trial.

Blair CK, Kelly AS, Steinberger J, Eberly LE, Napurski C, Robien K, Neglia JP, Mulrooney DA, Ross JA.

Pediatr Blood Cancer. 2014 Dec;61(12):2290-6. doi: 10.1002/pbc.25202. Epub 2014 Aug 30.

37.

The Clinical and Research Infrastructure of a Childhood Cancer Survivor Program.

Sadak KT, Bahr TL, Moen C, Neglia JP, Jatoi A.

J Cancer Educ. 2015 Sep;30(3):471-6. doi: 10.1007/s13187-014-0713-z.

PMID:
25099236
38.

Risk of late effects of treatment in children newly diagnosed with standard-risk acute lymphoblastic leukaemia: a report from the Childhood Cancer Survivor Study cohort.

Essig S, Li Q, Chen Y, Hitzler J, Leisenring W, Greenberg M, Sklar C, Hudson MM, Armstrong GT, Krull KR, Neglia JP, Oeffinger KC, Robison LL, Kuehni CE, Yasui Y, Nathan PC.

Lancet Oncol. 2014 Jul;15(8):841-51. doi: 10.1016/S1470-2045(14)70265-7. Epub 2014 Jun 19.

39.

6MP adherence in a multiracial cohort of children with acute lymphoblastic leukemia: a Children's Oncology Group study.

Bhatia S, Landier W, Hageman L, Kim H, Chen Y, Crews KR, Evans WE, Bostrom B, Casillas J, Dickens DS, Maloney KW, Neglia JP, Ravindranath Y, Ritchey AK, Wong FL, Relling MV.

Blood. 2014 Oct 9;124(15):2345-53. doi: 10.1182/blood-2014-01-552166. Epub 2014 May 14.

40.

Breast cancer after chest radiation therapy for childhood cancer.

Moskowitz CS, Chou JF, Wolden SL, Bernstein JL, Malhotra J, Novetsky Friedman D, Mubdi NZ, Leisenring WM, Stovall M, Hammond S, Smith SA, Henderson TO, Boice JD, Hudson MM, Diller LR, Bhatia S, Kenney LB, Neglia JP, Begg CB, Robison LL, Oeffinger KC.

J Clin Oncol. 2014 Jul 20;32(21):2217-23. doi: 10.1200/JCO.2013.54.4601. Epub 2014 Apr 21.

41.

Noncancer-related mortality risks in adult survivors of pediatric malignancies: the childhood cancer survivor study.

Cox CL, Nolan VG, Leisenring W, Yasui Y, Ogg SW, Mertens AC, Neglia JP, Ness KK, Armstrong GT, Robison LL.

J Cancer Surviv. 2014 Sep;8(3):460-71. doi: 10.1007/s11764-014-0353-7. Epub 2014 Apr 10.

42.

The contribution of neurocognitive functioning to quality of life after childhood acute lymphoblastic leukemia.

Kunin-Batson A, Kadan-Lottick N, Neglia JP.

Psychooncology. 2014 Jun;23(6):692-9. doi: 10.1002/pon.3470. Epub 2014 Feb 4.

PMID:
24497266
43.

Hyaluronan synthase 3 variant and anthracycline-related cardiomyopathy: a report from the children's oncology group.

Wang X, Liu W, Sun CL, Armenian SH, Hakonarson H, Hageman L, Ding Y, Landier W, Blanco JG, Chen L, Quiñones A, Ferguson D, Winick N, Ginsberg JP, Keller F, Neglia JP, Desai S, Sklar CA, Castellino SM, Cherrick I, Dreyer ZE, Hudson MM, Robison LL, Yasui Y, Relling MV, Bhatia S.

J Clin Oncol. 2014 Mar 1;32(7):647-53. doi: 10.1200/JCO.2013.50.3557. Epub 2014 Jan 27.

44.

Everyday executive function in standard-risk acute lymphoblastic leukemia survivors.

Walsh KS, Paltin I, Gioia GA, Isquith P, Kadan-Lottick NS, Neglia JP, Brouwers P.

Child Neuropsychol. 2015;21(1):78-89. doi: 10.1080/09297049.2013.876491. Epub 2014 Jan 16.

PMID:
24428397
45.

A systematic review of dental late effects in survivors of childhood cancer.

Gawade PL, Hudson MM, Kaste SC, Neglia JP, Constine LS, Robison LL, Ness KK.

Pediatr Blood Cancer. 2014 Mar;61(3):407-16. doi: 10.1002/pbc.24842. Epub 2013 Nov 1. Review.

46.

Evaluation of traditional and novel measures of cardiac function to detect anthracycline-induced cardiotoxicity in survivors of childhood cancer.

Dietz AC, Sivanandam S, Konety S, Kaufman CL, Gage RM, Kelly AS, Neglia JP, Mulrooney DA.

J Cancer Surviv. 2014 Jun;8(2):183-9. doi: 10.1007/s11764-013-0326-2. Epub 2013 Dec 7.

47.

Health conditions and quality of life in survivors of childhood acute myeloid leukemia comparing post remission chemotherapy to BMT: a report from the children's oncology group.

Schultz KA, Chen L, Chen Z, Kawashima T, Oeffinger KC, Woods WG, Nicholson HS, Neglia JP.

Pediatr Blood Cancer. 2014 Apr;61(4):729-36. doi: 10.1002/pbc.24881. Epub 2013 Nov 27.

48.

Telomere content and risk of second malignant neoplasm in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.

Gramatges MM, Liu Q, Yasui Y, Okcu MF, Neglia JP, Strong LC, Armstrong GT, Robison LL, Bhatia S.

Clin Cancer Res. 2014 Feb 15;20(4):904-11. doi: 10.1158/1078-0432.CCR-13-2076. Epub 2013 Nov 25.

49.

Assessment of physical performance using the 6-minute walk test in children receiving treatment for cancer.

Hooke MC, Garwick AW, Neglia JP.

Cancer Nurs. 2013 Sep-Oct;36(5):E9-E16. doi: 10.1097/NCC.0b013e31829f5510.

PMID:
23963198
50.

The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: a report from the Childhood Cancer Survivor Study.

Green DM, Nolan VG, Goodman PJ, Whitton JA, Srivastava D, Leisenring WM, Neglia JP, Sklar CA, Kaste SC, Hudson MM, Diller LR, Stovall M, Donaldson SS, Robison LL.

Pediatr Blood Cancer. 2014 Jan;61(1):53-67. doi: 10.1002/pbc.24679. Epub 2013 Aug 12.

Supplemental Content

Loading ...
Support Center